1. CABG Outlasts Stenting for Survival. Coronary artery bypass grafting (CABG) was associated with better longer-term survival compared with percutaneous coronary intervention (PCI) in certain high-risk subgroups.
2. Birth Control Pills Recalled. Pfizer has recalled a total of 28 lots of Lo/Ovral and its generic equivalent because of a packaging error that may result in inadequate contraception.
3. Patient Priorities Differ from Research Agenda. Clinical trial researchers tend to give equal weight to the components of a composite endpoint, but patients see things differently.